Last reviewed · How we verify
crystalloid cardioplegia solution
crystalloid cardioplegia solution is a Small molecule drug developed by Baskent University. It is currently FDA-approved.
Crystalloid cardioplegia solution is used in the treatment of various heart conditions, including aortic valve disease, mitral valve disease, and coronary artery disease. It is a type of oligosaccharide-based solution, which is also known as an anticoagulant heparin solution.
At a glance
| Generic name | crystalloid cardioplegia solution |
|---|---|
| Sponsor | Baskent University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact of Different Cardioplegia Solutions on Indicators of Myocardial Injury During Coronary Surgery (NA)
- Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery (PHASE3)
- Non-ischaemic Heart Preservation Versus Standard Cold Storage in Human Heart Transplantation (NA)
- Evaluation of Clinical Impact of the Type of Cardioplegia Used in the Patient Undergoing Major Cardiac Surgery. (PHASE4)
- Effects of Microplegia on Transfusion Rates After Cardiac Surgery (PHASE4)
- Comparison of Lactated Ringer's Solution and PlasmaLyte-A as a Base Solution for Del Nido Cardioplegia (NA)
- Del Nido Versus HTK Cardioplegia in Adult Aortic Valve Replacement (PHASE4)
- Comparative Study Between Conventional Crystalloid Cardioplegic Solution With Modified Del Nido Cardioplegia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- crystalloid cardioplegia solution CI brief — competitive landscape report
- crystalloid cardioplegia solution updates RSS · CI watch RSS
- Baskent University portfolio CI
Frequently asked questions about crystalloid cardioplegia solution
What is crystalloid cardioplegia solution?
Who makes crystalloid cardioplegia solution?
What development phase is crystalloid cardioplegia solution in?
Related
- Manufacturer: Baskent University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing